AU2125392A - Medicament against cancer and aids - Google Patents

Medicament against cancer and aids

Info

Publication number
AU2125392A
AU2125392A AU21253/92A AU2125392A AU2125392A AU 2125392 A AU2125392 A AU 2125392A AU 21253/92 A AU21253/92 A AU 21253/92A AU 2125392 A AU2125392 A AU 2125392A AU 2125392 A AU2125392 A AU 2125392A
Authority
AU
Australia
Prior art keywords
aids
against cancer
medicament against
adenine dinucleotide
nicotinamide adenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21253/92A
Other versions
AU653619B2 (en
Inventor
Jorg Univ.-Prof. DDR. Birkmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIRKMAYER JORG UNIV PROF DDR
Original Assignee
BIRKMAYER JORG UNIV PROF DDR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIRKMAYER JORG UNIV PROF DDR filed Critical BIRKMAYER JORG UNIV PROF DDR
Publication of AU2125392A publication Critical patent/AU2125392A/en
Application granted granted Critical
Publication of AU653619B2 publication Critical patent/AU653619B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Use of nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADPH) or of a physiologically tolerated salt thereof for the treatment of cancer or AIDS.
AU21253/92A 1991-08-26 1992-08-25 Medicament against cancer and AIDS Ceased AU653619B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4128625 1991-08-26
DE4128625A DE4128625A1 (en) 1991-08-26 1991-08-26 MEDICINE AGAINST CANCER AND AIDS

Publications (2)

Publication Number Publication Date
AU2125392A true AU2125392A (en) 1993-03-04
AU653619B2 AU653619B2 (en) 1994-10-06

Family

ID=6439356

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21253/92A Ceased AU653619B2 (en) 1991-08-26 1992-08-25 Medicament against cancer and AIDS

Country Status (13)

Country Link
EP (1) EP0534097B1 (en)
JP (1) JP3493202B2 (en)
AT (1) ATE150313T1 (en)
AU (1) AU653619B2 (en)
BR (1) BR9203302A (en)
CA (1) CA2072484C (en)
DE (2) DE4128625A1 (en)
DK (1) DK0534097T3 (en)
ES (1) ES2099772T3 (en)
GR (1) GR3023191T3 (en)
HU (1) HUT61895A (en)
NO (1) NO300915B1 (en)
ZA (1) ZA924902B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515916A (en) * 1997-09-11 2001-09-25 オクシジェン,インコーポレイテッド Therapeutic method using nicotinamide adenine dinucleotide and the like for the treatment of malignant and infectious diseases
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1162938B (en) * 1983-08-26 1987-04-01 Dino Spisni COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS
CA1336169C (en) * 1988-03-01 1995-07-04 Walther Birkmayer Agent for treatment of parkinson's disease

Also Published As

Publication number Publication date
NO923324L (en) 1993-03-01
JPH072678A (en) 1995-01-06
NO923324D0 (en) 1992-08-25
NO300915B1 (en) 1997-08-18
GR3023191T3 (en) 1997-07-30
JP3493202B2 (en) 2004-02-03
DE4128625C2 (en) 1993-08-12
DK0534097T3 (en) 1997-09-22
ATE150313T1 (en) 1997-04-15
DE59208223D1 (en) 1997-04-24
HUT61895A (en) 1993-03-29
ES2099772T3 (en) 1997-06-01
DE4128625A1 (en) 1993-04-08
CA2072484C (en) 2002-02-26
EP0534097A2 (en) 1993-03-31
EP0534097A3 (en) 1993-07-14
ZA924902B (en) 1993-04-28
AU653619B2 (en) 1994-10-06
BR9203302A (en) 1993-03-30
EP0534097B1 (en) 1997-03-19
CA2072484A1 (en) 1993-02-27

Similar Documents

Publication Publication Date Title
ES2051641A1 (en) Compounds and methods for inhibition of HIV and related viruses.
TW231268B (en)
CA2078670A1 (en) Compositions and methods for treatment of acne vulgaris and retardation of ageing
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
EP0345248A3 (en) Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
AU639097B2 (en) Medicament for treating hyperlipidaemia and/or atherosclerosis
AU2125392A (en) Medicament against cancer and aids
AU9010991A (en) Antidepressant
AU7719491A (en) Therapeutic compound
MY103748A (en) A new antitumor agent obtained by microbial stereoselective reduction of 4-deoxy-4-iododoxorubicin